(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOGENIUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ONCOGENIUS

ST13

US500000097289920

Class

35, 41, 42

Filing

97289920

Registration

7221297

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

11/21/2023

Trademark type

Combined

Nice classes

35, 41, 42

Filing date

03/01/2022

Registration date

11/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2023

Last transaction

11/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/09/2022

First use in commerce

03/09/2022

Drawing code

3

Owner type

16

Owner location

Bethesda, MD

Examiner

CROWLEY, SEAN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of three concentric circles, made up of evenly spaced, solid circles; the largest solid circles making the shape for the outermost circle, with each inner circle made up of solid circles in smaller proportion than the prior circle; to the right of the concentric circles is the term, "ONCOGENIUS".

Holders and representatives

Holders

Precision Medicine Group, LLC

Representatives

Donna H. Hartman OLENDERFELDMAN LLP

Technical classification

Nice Classes

Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing business management consulting servicesincluding advice and business strategies for payer and provider access decision making to oncology-based pharmaceutical and life sciences companies in the fields of launch planningaccess strategydata orchestrationpredictive analyticsproduct uptake forecastingpromotional focusmarket adoption; Providing business management consultation services in the fields of promotion opportunity assessmentpromotion effectivenesspayer promotion strategyaccount manager and sales force promotion strategydistribution strategy

Class 41

Providing online non-downloadable electronic publications in the nature of articlespublicationsinformational reports in the field of healthcare business for the healthcare industry

Class 42

Providing online non-downloadable software to utilize payor and provider access landscape information in the nature of articlespublicationsinformational reports in the field of healthcare business for the healthcare industry

Publications

History of USPTO decisions and trademark events.

36 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/05/2023

PUBO

PUBLISHED FOR OPPOSITION

09/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/16/2023

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

08/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/02/2023

IUAA

USE AMENDMENT ACCEPTED

08/02/2023

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

08/02/2023

IUAF

USE AMENDMENT FILED

08/02/2023

EAAU

TEAS AMENDMENT OF USE RECEIVED

08/01/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/26/2023

GNRT

NON-FINAL ACTION E-MAILED

07/26/2023

CNRT

NON-FINAL ACTION WRITTEN

07/26/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/13/2023

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/13/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/09/2023

PUBO

PUBLISHED FOR OPPOSITION

05/09/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/19/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/31/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/31/2023

ALIE

ASSIGNED TO LIE

03/31/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/31/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/31/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/31/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/14/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/14/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/14/2022

GNRT

NON-FINAL ACTION E-MAILED

12/14/2022

CNRT

NON-FINAL ACTION WRITTEN

12/14/2022

DOCK

ASSIGNED TO EXAMINER

11/29/2022

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/05/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/04/2022

NWAP

NEW APPLICATION ENTERED

03/04/2022

Continuous trademark protection

Get notified about every new filing that threatens ONCOGENIUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.